Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Paragon 28
(NYSE:FNA)
Intraday
$7.69
-0.09
[-1.16%]
After-Hours
$7.69
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$7.69
-0.09
[-1.16%]
At close: May 31
$7.69
0
[0.00%]
After Hours: 4:01PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Paragon 28 Stock (NYSE:FNA)
Paragon 28 Stock (NYSE: FNA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, May 09, 2024
JMP Securities Maintains Market Outperform on Paragon 28, Lowers Price Target to $20
Benzinga Newsdesk
-
May 9, 2024, 2:29PM
What Analysts Are Saying About Paragon 28 Stock
Benzinga Insights
-
May 9, 2024, 10:00AM
Piper Sandler Reiterates Overweight on Paragon 28, Lowers Price Target to $15
Benzinga Newsdesk
-
May 9, 2024, 8:29AM
Needham Maintains Buy on Paragon 28, Lowers Price Target to $14
Benzinga Newsdesk
-
May 9, 2024, 6:10AM
Wednesday, May 08, 2024
Paragon 28 Q1 Sales $61.10M Beat $59.66M Estimate
Benzinga Newsdesk
-
May 8, 2024, 4:06PM
Friday, April 05, 2024
Stephens & Co. Reiterates Overweight on Paragon 28, Maintains $18 Price Target
Benzinga Newsdesk
-
Apr 5, 2024, 9:15AM
Thursday, April 04, 2024
Unveiling 4 Analyst Insights On Paragon 28
Benzinga Insights
-
Apr 4, 2024, 4:00PM
Paragon 28 shares are trading lower after the company reported preliminary Q1 net revenue results.
Benzinga Newsdesk
-
Apr 4, 2024, 10:45AM
Needham Reiterates Buy on Paragon 28, Maintains $17 Price Target
Benzinga Newsdesk
-
Apr 4, 2024, 10:44AM
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
Avi Kapoor
-
Apr 4, 2024, 10:44AM
Paragon 28 CFO Stephen Deitsch To Depart Co. On Apr. 5, Co. Appoints Kristina Wright As Interim CFO
Benzinga Newsdesk
-
Apr 4, 2024, 8:04AM
Paragon 28 Sees Prelim. Q1 Net Revenue $60.8M-$61.1M vs $60.11M Est.
Benzinga Newsdesk
-
Apr 4, 2024, 8:03AM
Thursday, March 28, 2024
Paragon 28 Adds To Suite Of Novel Syndesmosis Repair Solutions With Launch Of Grappler R3INFORCE Extraosseous Repair System
Benzinga Newsdesk
-
Mar 28, 2024, 4:32PM
Needham Reiterates Buy on Paragon 28, Maintains $17 Price Target
Benzinga Newsdesk
-
Mar 28, 2024, 5:41AM
Tuesday, March 19, 2024
Around $9M Bet On Cardlytics? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
-
Mar 19, 2024, 9:09AM
Friday, March 01, 2024
Needham Maintains Buy on Paragon 28, Raises Price Target to $17
Benzinga Newsdesk
-
Mar 1, 2024, 8:01AM
Thursday, February 29, 2024
Paragon 28 Sees 2024 Revenue $249M-$259M vs $256.05M Est.
Benzinga Newsdesk
-
Feb 29, 2024, 4:38PM
Recap: Paragon 28 Q4 Earnings
Benzinga Insights
-
Feb 29, 2024, 4:20PM
Paragon 28 Q4 2023 Adj EPS $(0.170) Misses $(0.090) Estimate, Sales $60.561M Beat $60.461M Estimate
Benzinga Newsdesk
-
Feb 29, 2024, 4:17PM
Earnings Scheduled For February 29, 2024
Benzinga Insights
-
Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Earnings Outlook For Paragon 28
Benzinga Insights
-
Feb 28, 2024, 11:01AM
Thursday, February 01, 2024
Paragon 28 Launches PRECISION MIS Bunion System
Benzinga Newsdesk
-
Feb 1, 2024, 8:20AM
Friday, January 26, 2024
Paragon 28 Has Launched Mister Tendon System Which Allows Surgeons To Perform A Distal Cut Of The Flexor Hallucis Longus Or Flexor Digitorum Longus Tendon Through A Minimally Invasive Incision
Benzinga Newsdesk
-
Jan 26, 2024, 8:08AM
Wednesday, January 17, 2024
Paragon 28 Announces First Cases and Limited Market Release Of The Bun-Yo-Matic – A Next Generation Clamp And Cut Guide System For Lapidus Bunion Procedures
Benzinga Newsdesk
-
Jan 17, 2024, 8:04AM
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 8, 2024, 1:36PM
Paragon 28 shares are trading lower after the company issued preliminary Q4 and FY23 revenue guidance.
Benzinga Newsdesk
-
Jan 8, 2024, 12:29PM
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
Avi Kapoor
-
Jan 8, 2024, 11:46AM
Paragon 28 Sees Prelim. Q4 Revenue $60.3M-$60.6M vs $52.09M Est., Sees Prelim. 2023 Revenue $216.1M-$216.4M vs $216.09M Est.
Benzinga Newsdesk
-
Jan 8, 2024, 9:30AM
Monday, November 13, 2023
Paragon 28 Adds Second Mobile Medical Education Lab Significantly Expanding Upon Wildly Successful Foot And Ankle Surgeon Training Program
Benzinga Newsdesk
-
Nov 13, 2023, 5:29PM
Wednesday, November 08, 2023
Paragon 28 shares are trading lower after the company reported Q3 financial results. Also, Needham maintained a Buy rating on the stock but lowered its price target from $24 to $14.
Benzinga Newsdesk
-
Nov 8, 2023, 1:15PM
Needham Maintains Buy on Paragon 28, Lowers Price Target to $14
Benzinga Newsdesk
-
Nov 8, 2023, 5:50AM
Tuesday, November 07, 2023
Paragon 28 Sees FY23 Revenue $214M-$218M Vs $217.35M Est.
Benzinga Newsdesk
-
Nov 7, 2023, 7:34PM
Paragon 28 Q3 Sales $52.80M Beat $52.18M Estimate
Benzinga Newsdesk
-
Nov 7, 2023, 5:18PM
Earnings Scheduled For November 7, 2023
Benzinga Insights
-
Nov 7, 2023, 6:34AM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Friday, September 29, 2023
William Blair Initiates Coverage On Paragon 28 with Outperform Rating
Benzinga Newsdesk
-
Sep 29, 2023, 11:32AM
Monday, September 11, 2023
Paragon 28 Gets FDA Approval For IDE Feasibility Study Of Its SMART Total Talus System For Use In Conjunction With APEX 3D Total Ankle Replacement System
Benzinga Newsdesk
-
Sep 11, 2023, 7:08AM
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 22, 2023, 1:51PM
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 8, 2023, 1:32PM
Thursday, August 03, 2023
Needham Reiterates Buy on Paragon 28, Maintains $24 Price Target
Benzinga Newsdesk
-
Aug 3, 2023, 6:43AM
Wednesday, August 02, 2023
Paragon 28 Q2 EPS $(0.13) Misses $(0.10) Estimate, Sales $51.01M Beat $50.10M Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 5:30PM
Paragon 28 Q2 Sales $51.00M Beat $49.96M Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 5:17PM
Earnings Scheduled For August 2, 2023
Benzinga Insights
-
Aug 2, 2023, 8:45AM
Tuesday, August 01, 2023
Preview: Paragon 28's Earnings
Benzinga Insights
-
Aug 1, 2023, 3:01PM
Friday, May 05, 2023
JMP Securities Reiterates Market Outperform on Paragon 28, Maintains $30 Price Target
Benzinga Newsdesk
-
May 5, 2023, 8:51AM
Thursday, May 04, 2023
Paragon 28: Q1 Earnings Insights
Benzinga Insights
-
May 4, 2023, 4:50PM
Paragon 28 Q1 EPS $(0.11) Misses $(0.10) Estimate, Sales $52.04M Beat $49.97M Estimate
Benzinga Newsdesk
-
May 4, 2023, 4:48PM
Earnings Scheduled For May 4, 2023
Benzinga Insights
-
May 4, 2023, 6:34AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch